Equities

Precision Optics Corporation Inc

POCI:NAQ

Precision Optics Corporation Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)6.20
  • Today's Change0.35 / 5.98%
  • Shares traded60.83k
  • 1 Year change+5.62%
  • Beta0.1511
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Precision Optics Corporation Inc grew revenues 34.23% from 15.68m to 21.04m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -928.42k to -144.61k.
Gross margin33.65%
Net profit margin-8.43%
Operating margin-7.27%
Return on assets-8.98%
Return on equity-15.62%
Return on investment-13.18%
More ▼

Cash flow in USDView more

In 2023, Precision Optics Corporation Inc increased its cash reserves by 383.01%, or 2.32m. Cash Flow from Financing totalled 2.45m or 11.66% of revenues. In addition the company used 81.09k for operations while cash used for investing totalled 52.50k.
Cash flow per share-0.2383
Price/Cash flow per share--
Book value per share1.86
Tangible book value per share0.3544
More ▼

Balance sheet in USDView more

Precision Optics Corporation Inc has a Debt to Total Capital ratio of 19.82%, a higher figure than the previous year's 18.16%.
Current ratio1.64
Quick ratio1.05
Total debt/total equity0.2472
Total debt/total capital0.1982
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.